Results 31 to 40 of about 170,262 (217)

LASER safety measures for the treatment of genital warts in HIV+ patients during the COVID-19 pandemic. [PDF]

Dermatol Ther, 2020
Cameli N, Mariano M, Latini A, Morrone A, Cristaudo A.   +4 more
europepmc   +3 more sources

Treatment of Genital Warts with a Combination of Cryotherapy and 5% Imiquimod [PDF]

Journal of Clinical and Diagnostic Research, 2020
Genital warts (condyloma acuminata) are benign, proliferative tumours which occur in the genital, anal, perineal and/or perianal areas. These warts are caused by Human Papilloma Virus (HPV).
Sneha Deshmukh, Sudhir Singh, Sugat Jawade, Bhushan Madke, Adarsh Lata Singh   +4 more
doaj   +1 more source

Laser therapy in cutaneous and genital warts: A review article

Dermatologic Therapy, 2020
Traditional treatment modalities for wart require long‐term treatment course and usually have high recurrence rates and unwanted side effects. In this review article, we evaluated different types of laser therapy in the treatment of warts.
B. Iranmanesh, M. Khalili, Hamed Zartab, Rezvan Amiri, Mahin Aflatoonian   +4 more
semanticscholar   +1 more source

Frequency of high risk human papillomavirus (HPV) serotypes in cervicovaginal smear of wives of men with genital warts and its relation with Pap smear [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2022
Introduction: Human papillomavirus is the leading cause of cervical cancer and with timely diagnosis and prompt treatment of these infections, the progression of cervical cancer can be prevented.
Soroush Pahlevan, Vahid Sepehr, Alireza Rezaei, Farzaneh Pardehshenas   +3 more
doaj   +1 more source

The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis

BMC Public Health, 2020
Background The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection against genital warts (GW) as well as cervical cancer.
A. Lukács, Zsuzsanna Máté, N. Farkas, A. Mikó, J. Tenk, P. Hegyi, B. Németh, L. M. Czumbel, Sadaeng Wuttapon, I. Kiss, Z. Gyöngyi, G. Varga, Z. Rumbus, A. Szabó   +13 more
semanticscholar   +1 more source

Efficacy of inosine pranobex as an adjuvant oral therapy in anogenital warts: an evidence-based case report [PDF]

JDVI (Journal of General Procedural Dermatology & Venereology Indonesia), 2019
Background: Human papillomavirus (HPV) causes the most prevalent sexually transmitted infection and is an important etiological factor in genital cancer.
Benny Nelson, Indina Sastrini, Lidwina Anissa, Patricsia Manalu, Peppy Fourina, Rahmaniar Desianti Kuraga, Wresti Indriatmi   +6 more
doaj   +1 more source

Epidemiological trends and economic burden of genital warts in Dutch primary care. [PDF]

BMJ Public Health
Veijer C, Bes JM, Dolk C, Postma MJ, de Jong LA.   +4 more
europepmc   +3 more sources

Nonavalent human papillomavirus vaccination as alternative treatment for genital warts

Dermatologic Therapy, 2020
Genital warts caused by the human papillomavirus (HPV) are the most common sexually transmitted disease and have a negative impact on quality of life.
S. Bossart, M. Gabutti, S. S. Seyed Jafari, R. Hunger   +3 more
semanticscholar   +1 more source

Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study

BMC Infectious Diseases, 2008
Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is also responsible for benign condylomata acuminata, also known as genital warts. We assessed the incidence of genital warts in Germany and collected information on their
Bénard Stève, Gieseking Friederike, Breugelmans J Gabrielle, Hillemanns Peter, Lamure Emilie, Littlewood Kavi J, Petry Karl U   +6 more
doaj   +1 more source

Cantharidin as an Alternative Treatment for Genital Warts: A Case Monitored With Optical Coherence Tomography. [PDF]

Acta Derm Venereol, 2020
Ruini C, Clanner-Engelshofen BM, Heppt M, Herzinger T, Sárdy M, Ruzicka T, French LE, Reinholz M.   +7 more
europepmc   +3 more sources